if they don't get any money from the cap raising, as I suspect, they might go into voluntary suspension to avoid public scrutiny.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025